BPA Call 36C24823A0010-36C24823N0294

Award Date 2/8/23
Potential Completion Date 1/31/28
Potential Value $373K
Ultimate Awardee
Veracyte, Inc.
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract, valued at $194,435.40, is a Blanket Purchase Agreement (BPA) call order issued under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) contract vehicle. The contract is for Veracyte Labs to provide its proprietary Decipher Prostate Cancer Test, a genomic classifier that...
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 10 (VISN 10), part of the Department of Veterans Affairs (VA), to Veracyte Labs SD Corporation, a division of Veracyte, Inc. The contract, valued at $311,096.64, is for the company's Decipher Prostate Cancer Test, a proprietary genomic classifier that helps clinicians make more informed treatment decisions for prostate cancer. The contract does not have a set-aside designation, reflecting the...
This is a firm fixed-price delivery order awarded to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 10. The $84,255.34 contract is for the company's Decipher Prostate Cancer Testing services, which provide genomic analysis to help clinicians make more informed treatment decisions for prostate cancer patients. Veracyte is a for-profit organization that specializes in advanced molecular...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the modification and delivery of the Decipher Prostate Cancer Testing service. The contract, valued at $64,811.80, is a Blanket Purchase Agreement (BPA) call placed under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract supports the VA's goal of providing personalized cancer care to...
This federal contract award, valued at $184,713.63, was made by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc. The contract is for the provision of the Decipher Prostate Cancer Test, a specialized genomic classifier that analyzes tumor gene expression patterns to help clinicians make more informed treatment decisions for prostate cancer patients. The contract is a Blanket Purchase...
This firm fixed price delivery order was awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, operating through its Decipher Biosciences, Inc. division. The $9,722 contract calls for the provision of Veracyte's proprietary Decipher Molecular Prostate Oncology Assay, which utilizes genomic testing to analyze tumor gene expression patterns and aid in personalized treatment planning for prostate cancer patients. The award was made under Veracyte's existing Federal...
The Department of Veterans Affairs (VA) awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., to provide prostate cancer genomic testing services. The contract, valued at $390,000.00, has an ultimate completion date of January 31, 2025. Veracyte Labs SD Corporation holds a Federal Supply Schedule (FSS-621-II) contract for Medical Laboratory Testing and Analysis Services, which serves as the parent vehicle for...
This is a federal contract award to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., for DECIPHER PROSTATE CANCER TESTING services. The contract, valued at $3,240.59, was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA). This is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract does...
This is a federal contract award issued by the Veterans Integrated Service Network 1 (VISN 1), which is part of the U.S. Department of Veterans Affairs (VA), to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is for $300,000.00 and involves the provision of prostate cancer genomic testing and analysis services through a Blanket Purchase Agreement (BPA) call under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II)...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call contract to Veracyte Labs SD Corporation, operating through its Decipher Biosciences, Inc. division, for $294,893.69 to provide the Decipher Prostate Cancer Test. This specialized genomic test analyzes tumor gene expression patterns to help clinicians make more informed treatment decisions for prostate cancer patients, supporting the VA's efforts to deliver precision medicine for veterans. The contract...

This is a firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte Labs SD Corporation, a division of Veracyte, Inc. The contract, valued at $372,667.85, is for the delivery of the Decipher Prostate Cancer Test, a specialized genomic diagnostic service that analyzes tumor gene expression patterns to help clinicians assess prostate cancer risk and guide treatment decisions.

The contract is a Blanket Purchase Agreement under the General Services Administration's Medical Laboratory Testing and Analysis Services schedule, which enables VISN 8 and other VA healthcare networks to efficiently procure Veracyte's proprietary testing services through task orders. This contract supports the VA's efforts to provide precision medicine and personalized cancer care to veterans. The contract has no set-aside designation, reflecting the specialized nature of Veracyte's genomic testing capabilities. The contract will be performed at Veracyte's laboratories in San Diego, California, with an ultimate completion date of January 31, 2028.

Generated 2/14/25, 9:01 AM